Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating a combination chemotherapy regimen for recurrent or metastatic colorectal cancer; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Stony Brook University | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN